Radiomics has been used extensively to predict the local response for BrMs after stereotactic radiosurgery100, differentiate between BrMs and glioblastoma101, predict the primary tumor of origin102, assess the diagnostic ability of BrMs to predict EGFR mutation status in primary lung cancer BrMs103, and predict survival104. This evidence concerns the gene EGFR and lung carcinoma.